Abstract

Caspase-1 activated in inflammasomes triggers a programmed necrosis called pyroptosis, which is mediated by gasdermin D (GSDMD). However, GSDMD-deficient cells are still susceptible to caspase-1-mediated cell death. Therefore, here, we investigate the mechanism of caspase-1-initiated cell death in GSDMD-deficient cells. Inflammasome stimuli induce apoptosis accompanied by caspase-3 activation in GSDMD-deficient macrophages, which largely relies on caspase-1. Chemical dimerization of caspase-1 induces pyroptosis in GSDMD-sufficient cells, but apoptosis in GSDMD-deficient cells. Caspase-1-induced apoptosis involves the Bid-caspase-9-caspase-3 axis, which can be followed by GSDME-dependent secondary necrosis/pyroptosis. However, Bid ablation does not completely abolish the cell death, suggesting the existence of an additional mechanism. Furthermore, cortical neurons and mast cells exhibit little or low GSDMD expression and undergo apoptosis after oxygen glucose deprivation and nigericin stimulation, respectively, in a caspase-1- and Bid-dependent manner. This study clarifies the molecular mechanism and biological roles of caspase-1-induced apoptosis in GSDMD-low/null cell types.

In inflammasomes, caspase-1 activation leads to pyroptosis mediated by gasdermin D, but cells lacking gasdermin-D still initiate caspase-dependent cell death. Here, Tsuchiya et al. show that these cells undergo Bid- and caspase-3-dependent apoptosis.

Details

Title
Caspase-1 initiates apoptosis in the absence of gasdermin D
Author
Tsuchiya Kohsuke 1 ; Nakajima Shinsuke 2 ; Hosojima Shoko 2 ; Thi Nguyen Dinh 3   VIAFID ORCID Logo  ; Hattori Tsuyoshi 3   VIAFID ORCID Logo  ; Manh Le Thuong 3 ; Hori Osamu 3 ; Mahib Mamunur Rashid 2 ; Yamaguchi Yoshifumi 4   VIAFID ORCID Logo  ; Miura Masayuki 5   VIAFID ORCID Logo  ; Kinoshita Takeshi 2 ; Kushiyama Hiroko 2 ; Sakurai Mayumi 2 ; Shiroishi Toshihiko 6 ; Suda Takashi 2 

 Kanazawa University, Division of Immunology and Molecular Biology, Cancer Research Institute, Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329); Kanazawa University, Institute for Frontier Science Initiative (InFiniti), Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329) 
 Kanazawa University, Division of Immunology and Molecular Biology, Cancer Research Institute, Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329) 
 Kanazawa University, Department of Neuroanatomy, Graduate School of Medical Sciences, Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329) 
 Hokkaido University, Institute of Low Temperature Science, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691) 
 The University of Tokyo, Department of Genetics, Graduate School of Pharmaceutical Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Genetic Strains Research Center, National Institute of Genetics, Mammalian Genetics Laboratory, Shizuoka, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2221216577
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.